U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT07469579) titled 'ALPs Single ChambEr New Device Study' on March 02.
Brief Summary: Prospective, non-randomized, multi-center, international study designed to evaluate the initial safety and performance of the ALPS leadless pacemaker when used in patients with bradycardia.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Brady-tachy Syndrome
Brady Arrythmia
Bradycardia
AV Block
Atrial Fibrillation (Paroxysmal)
Intervention:
DEVICE: Leadless ventricular pacemaker implantation
Participants will undergo leadless ventricular pacemaker implantation providing pacing therapy by the implant and monitoring using the home monitor.
Re...